Axon Enterprise, Inc. (AXON) financials
NASDAQ · Industrials · Aerospace & Defense · 5,100 employees · CEO Patrick W. Smith
- Price
- $427.77 -2.35%
- Market cap
- $34.8B
- Enterprise value
- $36B
- Last report
- Q2 '26 filed 2026-08-06
- Next report
- 2026-11-05 EPS est. $1.89
Valuation & key figures
- Market cap
- $34.8B EV $36B
- Revenue
- $3.22B Trailing 12 months
- Revenue growth
- +34% FY2026 consensus
- Profit margin
- 6.2% Net income / revenue, TTM
- P/E
- 172.3× Forward 55.7× (FY2026)
- P/S
- 10.8× Price / sales, TTM
- EV / EBITDA
- 75.4× TTM
- Free cash flow
- $133M Trailing 12 months
- Net income
- $200M Trailing 12 months
- Revenue estimate
- $3.71B FY2026 consensus
- Earnings
- 2026-11-05 Revenue est. $937M
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-05): revenue beat by 3.2%, EPS beat by 2.2%Revenue $904M vs $876M expected (+3.2%); EPS $1.88 vs $1.84 (+2.2%).
- Revenue growth accelerating: 35.3% year on yearQ2 '26 revenue $904M, against an average of 33.9% over the four quarters before.
- Operating margin 2.6% (TTM), +2.5 pp on a year agoOperating income grew 4,322.4% while revenue grew 34.6%.
- 66.9% of pre-tax profit is non-operatingPre-tax income $254M vs operating income $83.9M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 4.1% of revenue (a year ago 4.1%)$133M invested in the last 4 quarters (+33.8% on a year earlier). Free cash flow $133M = 66.7% of net income.
- Returned $130M to shareholders = 97.6% of free cash flowBuybacks $130M (a year earlier $0), dividends $0, stock-based pay $633M (TTM).
- Diluted share count up 0.6% in a year82.5M diluted shares in Q2 '26, 82.1M a year earlier.
- Net debt $1.14BCash + short-term investments $693M, debt incl. leases $1.83B; a year ago net cash $179M.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $904M | $669M | +35.3% |
| Gross margin | 60.4% | 60.4% | 0.0 pp |
| Operating income | $46.8M | $1.06M | +4,296.4% |
| Operating margin | 5.2% | 0.2% | +5.0 pp |
| Net income | $29.4M | $36.1M | -18.5% |
| Diluted EPS | $0.36 | $0.44 | -18.2% |
| Operating cash flow | $20.1M | -$91.7M | +121.9% |
| Capex | $21M | $23M | -8.3% |
| Free cash flow | -$972K | -$115M | +99.2% |
| R&D | $209M | $163M | +28.4% |
| Stock-based compensation | $144M | $139M | +3.4% |
Reported vs consensus
2026-08-05| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $904M | $876M | +3.2% |
| EPS (as estimated) | $1.88 | $1.84 | +2.2% |
From the report of 2026-08-05 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Software And Sensors Segment | $398M | – | 44.0% | $1.96B | – | |
| Taser X2 | $261M | – | 28.9% | $1.41B | – | |
| Axon Body | $95.4M | – | 10.5% | $601M | – | |
| Platform Solutions | $150M | – | 16.6% | $527M | – |
Revenue by region
share of total| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| United States | $742M | +38.1% | 82.1% | $2.63B | +29.8% | |
| Non-US | $162M | +23.6% | 17.9% | $592M | +61.8% |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $266M
- Capex
- -$133M
- Buybacks
- -$130M
- Dividends
- $0
- Acquisitions
- -$1.19B
- Net debt issued
- -$283M
- Stock-based compensation
- $633M
- Free cash flow
- $133M
- Returned to shareholders / FCF
- 97.6%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 172.3× | 165.9× 4 of 5 years | 80.2× – 355.0× |
| EV / EBITDA | 75.4× | 125.4× 4 of 5 years | 55.0× – 236.1× |
| EV / Sales | 11.2× | 14.6× | 10.2× – 22.1× |
| Price / FCF | 260.9× | 219.8× | 65.8× – 608.1× |
| Price / Book | 9.4× | 12.9× | 9.3× – 19.3× |
| FCF yield | 0.4% | 0.8% | 0.2% – 1.5% |
| Return on invested capital | 1.1% | 0.8% | -5.6% – 6.0% |
| Return on equity | 5.9% | 7.4% | -5.7% – 16.2% |
Analysts
Consensus target $633.63 (+48.1%)
range $440.00 – $750.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $3.71B | +33.5% | $7.68 | +408.8% | 55.7× | 12 |
| FY2027 | $4.81B | +29.5% | $10.57 | +37.5% | 40.5× | 12 |
| FY2028 | $6.16B | +28.3% | $13.80 | +30.6% | 31.0× | 3 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 301 figures Axon Enterprise, Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts and Financing Receivable, after Allowance for Credit Loss, Current | $769M | $628M | +22.4% | $777M | $548M | +42.0% |
| Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent | $1.6M | $1.63M | -2.1% | $6.07M | $3.46M | +75.3% |
| Accounts Payable, Current | $270M | $118M | +128.6% | $139M | $72M | +93.3% |
| Accounts Receivable, Allowance for Credit Loss | $7.8M2025-12-31 | $5.6M | +39.3% | $7.8M | $5.6M | +39.3% |
| Accounts Receivable, Allowance for Credit Loss, Current | $4.95M | $3.48M | +42.3% | $4.2M | $3.32M | +26.4% |
| Accounts Receivable, Allowance for Credit Loss, Noncurrent | $48K2025-09-30 | $48K | 0.0% | $48K2024-12-31 | $44K | +9.1% |
| Accounts Receivable, Allowance for Credit Loss, Writeoff | $841K2025-09-30 | $314K | +167.8% | $2.4M2024-12-31 | $754K | +218.8% |
| Accounts Receivable, Credit Loss Expense (Reversal) | $835K2025-09-30 | $581K | +43.7% | $4.03M2024-12-31 | $1.08M | +272.0% |
| Accrued Bonuses, Current | $32.4M | $35.7M | -9.2% | $78.4M | $59.8M | +31.2% |
| Accrued Income Taxes | $33M | $12.7M | +159.9% | $27.3M | $27.9M | -1.9% |
| Accrued Liabilities, Current | $424M | $266M | +59.5% | $511M | $279M | +82.9% |
| Accrued Professional Fees, Current | $32.6M | $6.71M | +385.9% | $7.52M | $7.85M | -4.1% |
| Accrued Sales Commission, Current | $85.2M | $45.2M | +88.8% | $151M | $88.2M | +70.9% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $181M2025-12-31 | $136M | +33.3% | $181M | $136M | +33.3% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$16.4M | -$12.7M | -29.1% | -$11.8M | -$18.2M | +35.1% |
| Additional Paid in Capital, Common Stock | $2.74B | $1.96B | +39.2% | $2.48B | $1.69B | +46.5% |
| Adjustments to Additional Paid in Capital, Other | -$2.33M2026-03-31 | -$16M | +85.5% | -$21.4M | – | – |
| Amortization of Intangible Assets | $13.4M | $6.7M | +100.0% | $29.8M | $17.4M | +71.3% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 5.43M | 5.77M | -5.9% | 4.83M | 8.79M | -45.1% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $144M | $139M | +3.4% | $634M | $383M | +65.8% |
| APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition | $1.35M2026-03-31 | – | – | $5.3M | $2.87M | +84.4% |
| APIC, Share-based Payment Arrangement, Recognition and Exercise | -$128M | -$188M | +31.7% | -$352M | -$58.2M | -504.9% |
| Asset Impairment Charges | – | – | – | $0 | $0 | – |
| Assets | $7.48B | $6.22B | +20.4% | $7B | $4.47B | +56.4% |
| Assets, Current | $3B | $3.83B | -21.5% | $3.71B | $2.3B | +61.6% |
| Capital Expenditures Incurred but Not yet Paid | $2.08M | $2.91M | -28.6% | $7.29M | $5.16M | +41.4% |
| Capitalized Contract Cost, Net | $333M2025-12-31 | $214M | +55.4% | $333M | $214M | +55.4% |
| Capitalized Contract Cost, Net, Current | $86.6M2025-12-31 | $59M | +46.7% | $86.6M | $59M | +46.7% |
| Capitalized Contract Cost, Net, Noncurrent | $246M2025-12-31 | $155M | +58.8% | $246M | $155M | +58.8% |
| Cash and Cash Equivalents, at Carrying Value | $598M | $615M | -2.9% | $1.2B | $455M | +164.1% |
| Cash and Cash Equivalents, Fair Value Disclosure | $262M | $112M | +133.3% | $168M | $94.9M | +77.3% |
| Cash Surrender Value, Fair Value Disclosure | $9.91M2025-12-31 | $8.4M | +18.1% | $9.91M | $8.4M | +18.1% |
| Cash, Cash Equivalents, and Short-term Investments | $693M | – | – | $90.4M2014-12-31 | $63.4M | +42.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $610M | $627M | -2.8% | $1.21B | $467M | +160.0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $138M | -$477M | +129.0% | $747M | -$134M | +657.6% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 200M | 200M | 0.0% | 200M | 200M | 0.0% |
| Common Stock, Shares, Issued | 102M | 98.7M | +2.8% | 100M | 96.8M | +3.7% |
| Common Stock, Shares, Outstanding | 81.2M | 78.5M | +3.5% | 80.2M | 76.6M | +4.7% |
| Common Stock, Value, Issued | $1K | $1K | 0.0% | $1K | $1K | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $24.3M | $41.3M | -41.3% | $131M | $370M | -64.5% |
| Contract with Customer, Asset, after Allowance for Credit Loss | $761M2025-12-31 | $488M | +56.0% | $761M | $488M | +56.0% |
| Contract with Customer, Asset, after Allowance for Credit Loss, Current | $751M | $463M | +62.1% | $583M | $368M | +58.4% |
| Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent | $296M | $162M | +83.1% | $178M | $120M | +48.7% |
| Contract with Customer, Asset, Allowance for Credit Loss | $3.33M2025-09-30 | $2.68M | +24.2% | $2.24M2024-12-31 | $1.52M | +47.7% |
| Contract with Customer, Liability | $1.07B2025-12-31 | $974M | +10.4% | $1.07B | $974M | +10.4% |
| Contract with Customer, Liability, Current | $671M | $603M | +11.2% | $715M | $613M | +16.6% |
| Contract with Customer, Liability, Noncurrent | $386M | $329M | +17.2% | $360M | $361M | -0.2% |
| Contract with Customer, Liability, Revenue Recognized | $213M | $184M | +15.8% | $682M | $500M | +36.6% |
| Cost of Goods and Services Sold | $358M | $265M | +35.2% | $1.12B | $841M | +33.3% |
| Current Federal Tax Expense (Benefit) | – | – | – | -$34.2M | $67.9M | -150.4% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $5.84M | $3.39M | +72.5% |
| Current Income Tax Expense (Benefit) | – | – | – | -$23M | $89.6M | -125.7% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $5.4M | $18.2M | -70.4% |
| Debt Conversion, Converted Instrument, Amount | – | – | – | $28.4M | – | – |
| Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | $18.2M | $24.7M | -26.5% | $20.4M | $9.71M | +109.9% |
| Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | $0 | -$523K | +100.0% | $43.5M | $0 | – |
| Debt Securities, Available-for-sale | $1.73B2025-12-31 | $986M | +75.8% | $1.73B | $986M | +75.8% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | $6.03M | $54.1M | -88.9% | $12.2M | $108M | -88.7% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $0 | $181K | -100.0% | $3K | $68K | -95.6% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02